Home Site Map Contact Us Social Media MSF Offices xml  

Visceral Leishmaniasis

Press Release | December 8, 2011

MSF Statement in Response to Gilead Donation of AmBisome for Visceral Leishmaniasis

MSF responds to Gilead Sciences's announcement that it will be donating drugs for the treatment of 50,000 patients suffering from visceral leishmaniasis.